Oak Thistle’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.17M Buy
+9,308
New +$2.15M 0.2% 204
2026
Q1
– Sell
-7,132
Closed -$1.24M – 511
2025
Q4
$1.24M Buy
7,132
+3,299
+86% +$601K 0.17% 250
2025
Q3
$730K Buy
3,833
+2,088
+120% +$371K 0.11% 322
2025
Q2
$313K Sell
1,745
-3,474
-67% -$603K 0.05% 408
2025
Q1
$883K Sell
5,219
-2,713
-34% -$446K 0.18% 216
2024
Q4
$1.2M Buy
7,932
+5,653
+248% +$879K 0.36% 95
2024
Q3
$354K Sell
2,279
-358
-14% -$53.5K 0.12% 305
2024
Q2
$361K Buy
+2,637
New +$361K 0.27% 166
2024
Q1
– Sell
-6,261
Closed -$863K – 346
2023
Q4
$863K Buy
6,261
+1,480
+31% +$195K 0.25% 163
2023
Q3
$583K Buy
4,781
+826
+21% +$110K 0.17% 250
2023
Q2
$556K Buy
+3,955
New +$545K 0.29% 139
2022
Q2
– Sell
-1,543
Closed -$211K – 240
2022
Q1
$211K Buy
+1,543
New +$215K 0.11% 341

Other funds holding DGX

Oak Thistle's DGX Position: Q3 2026 in Review

Oak Thistle opened a new position in Quest Diagnostics (DGX) in Q3 2026: 9,308 shares worth $2.17M. The stake represents 0.2% of the portfolio and ranks #204 among its holdings. This is a return to the name: Oak Thistle previously reported a position in DGX as recently as Q4 2025.

Oak Thistle first reported a position in DGX in Q1 2022 and has held it in 12 quarters since. 978 funds tracked by Wall St. Rank hold DGX as of Q3 2026.

  • Oak Thistle held 9,308 shares of Quest Diagnostics worth $2.17M as of Q3 2026.
  • Quest Diagnostics was a new Oak Thistle position in Q3 2026.
  • Quest Diagnostics made up 0.2% of Oak Thistle's portfolio in Q3 2026, its #204 holding.
  • Oak Thistle first reported a position in Quest Diagnostics in Q1 2022 and has held it in 12 quarters since.
  • 978 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.

Based on Oak Thistle's 13F filing for Q3 2026, filed 21 Oct 2026.